Logo
  • Cases & Projects
  • Developers
  • Contact
Sign InSign Up

© Copyright 2025 Many.Dev. All Rights Reserved.

Product
  • Cases & Projects
  • Developers
About
  • Contact
Legal
  • Terms of Service
  • Privacy Policy
  • Cookie Policy
Development of Next-Generation Immunogenomics SaaS Platform Features
  1. case
  2. Development of Next-Generation Immunogenomics SaaS Platform Features

This Case Shows Specific Expertise. Find the Companies with the Skills Your Project Demands!

You're viewing one of tens of thousands of real cases compiled on Many.dev. Each case demonstrates specific, tangible expertise.

But how do you find the company that possesses the exact skills and experience needed for your project? Forget generic filters!

Our unique AI system allows you to describe your project in your own words and instantly get a list of companies that have already successfully applied that precise expertise in similar projects.

Create a free account to unlock powerful AI-powered search and connect with companies whose expertise directly matches your project's requirements.

Development of Next-Generation Immunogenomics SaaS Platform Features

revolve.healthcare
Health & Fitness
Medical
Biotechnology
Pharmaceuticals

Need for Enhanced Functionality and Scalability

ENPICOM is experiencing increased demand for its IGX Platform. To meet this demand and remain competitive, there's a critical need to expand the platform's capabilities, improve performance, and ensure its long-term scalability. The current platform requires enhancements to support growing datasets and evolving user needs in immunogenomics research and antibody development.

About the Client

ENPICOM B.V. is a bioinformatics software engineering company providing SaaS solutions for immune system analysis, catering to academic research and biotechnology/pharmaceutical organizations.

Project Goals

  • Expand the functionality of the IGX Platform SaaS offering.
  • Improve the performance and stability of existing platform applications.
  • Enhance the scalability of the platform to accommodate growing data volumes and user base.
  • Maintain a focus on high-quality code and agile development practices.

Functional Requirements

  • Development of new IGX Platform applications based on user requirements.
  • Enhanced interactive data visualization tools for antibody screening and analysis.
  • Improved data processing and analysis pipelines.
  • Refined user interface (UI) for enhanced usability and intuitive navigation.

Preferred Technologies

Python
TypeScript
Rust
AWS
REST API
PostgreSQL
RabbitMQ
Kubernetes

Required Integrations

  • Potential integration with external sequencing data providers.
  • Integration with existing client systems and databases.

Non-Functional Requirements

  • High scalability to handle large datasets.
  • High performance for rapid data processing and analysis.
  • Robust security measures to protect sensitive data.
  • Maintainability and extensibility for future development.

Expected Business Impact

Successful completion of this project will enable ENPICOM to: expand its market reach by offering a more comprehensive and feature-rich SaaS platform, increase customer satisfaction through improved performance and usability, and solidify its position as a leader in the immunogenomics software market. This will lead to increased revenue and market share.

More from this Company

Automated Quality Control System for Pharmaceutical Testing
Development of ISO/IEC 62304 Compliant Python-Based Diagnostic Software for Cancer Detection
Development of a Medical-Grade Connected Health Platform for Multiple Sclerosis Patients with Wearable Device Integration and Clinical Analytics
Development of Integrated Patient-Pharmacist Communication and Management System
Development of a Mobile-First Digital Therapeutics Application for Post-Stroke Cognitive Rehabilitation